Press release
Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSNL)
An investigation for investors in Personalis, Inc. (NASDAQ: PSNL) shares over potential securities laws violations by Personalis,
Investors who purchased shares of Personalis, Inc. (NASDAQ: PSNL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Personalis, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Menlo Park, CA based Personalis, Inc. operates as a cancer genomics company worldwide. Personalis, Inc. conducted an initial public offering ("IPO") in June 2019. Shares of Personalis, Inc. (NASDAQ: PSNL) were offered at $17.00 per share in the IPO and reached a high of $31.88 immediately following the IPO. Shares of Personalis, Inc. (NASDAQ: PSNL) declined to as low as $2.7 per share on March 17, 2020.
On April 17, 2020, shares of Personalis, Inc. (NASDAQ: PSNL) closed at $8.81 per share.
Those who purchased shares of Personalis, Inc. (NASDAQ: PSNL) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSNL) here
News-ID: 2019406 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Personalis
Personalized Cancer Vaccines Market Overall Study Report 2022-2029 With Top Play …
Personalized Cancer Vaccines Market research covers segmentation and overlays cast a spotlight on the major market participants, emphasizing the favorable competitive landscape and long-term trends. The research looks at sales and revenue from the years 2022 to 2029, both historically and predicted. Understanding the segments aids in determining the importance of various elements that contribute to the growth of the Personalized Cancer Vaccines market. The report provides a qualitative analysis…
PERSONALIZED CANCER VACCINES MARKET SIZE & SHARE ANALYSIS BY NEON THERAPEUTICS, …
The Personalized Cancer Vaccines Market report explains the growing popularity of the market competition by leading manufacturers or players, with sales volume, revenue (Million USD), price (USD/Unit), and market share for every individual manufacturer or player. Furthermore, the scope of this Personalized Cancer Vaccines Market report includes in-depth insights of global and regional markets with the sense given for variation in the growth of the Pharmaceutical industry in certain regions.…
Global Precision Medicine Market Next Big Thing | Major Giants Neon Therapeutic …
Data Bridge Market Research has recently added a concise research on the Global Precision Medicine Market to depict valuable insights related to significant market trends driving the industry. Global Precision Medicine Market report comprises of crucial aspects of the market that contains industry research, market sizing & forecast, competitive intelligence, market entry strategy, pricing trends, sustainability trends, customer insights, technology evolution, innovation trends, and distribution channel assessment. With this report, businesses…
Investigation announced for Investors in shares of Personalis, Inc. (NASDAQ: PSN …
An investigation was announced concerning potential securities laws violations by Personalis, Inc. in connection with certain financial statements.
Investors who purchased shares of Personalis, Inc. (NASDAQ: PSNL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Personalis, Inc. regarding its business, its prospects and its operations were materially false and…
Gene Panel Market By Top Leading Players : Eurofins Scientific, F. Hoffmann-La R …
Worldwide Gene Panel Market Analysis to 2025 is a specialized and in-depth study of the Gene Panel industry with a focus on the global market trend. The report aims to provide an overview of global Gene Panel Market with detailed market segmentation by product/application and geography. The global Gene Panel Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status…
Gene Panel Market Global Outlook to 2025 - Personalis Inc., ArcherDX, Inc., QIAG …
Worldwide Gene Panel Market Analysis to 2025 is a specialized and in-depth study of the Gene Panel industry with a focus on the global market trend. The report aims to provide an overview of global Gene Panel Market with detailed market segmentation by product/application and geography. The global Gene Panel Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status…
